Women living in US counties with persistently low rates of cervical cancer screening face nearly double the risk of being ...

In the phase 2 SunRISe-1 trial, TAR-200, a slow-release intravesical device delivering gemcitabine, eliminated tumors in 82% ...

An NIH-funded trial found that two IV doses of dalbavancin, given a week apart, were as safe and effective as 4–6 weeks of ...

A multi-institutional team of researchers has trained AI to understand the “language” of proteins and design peptide drugs to ...

Using fiber optic technology, an international research team was able to measure for the first time that the impact of the ...

Researchers at The Hong Kong Polytechnic University developed two AI models – MMgSN-Net and PGMGVCE – to create virtual ...

A detailed analysis reveals one of the reasons the R21/Matrix-M malaria vaccine works so well: the antibodies generated ...

UC Irvine researchers found that women with Down syndrome have more advanced Alzheimer’s pathology than men at the same age ...

A new study from South Dakota State University reveals how grapevine canes can be converted into plastic-like material that ...

Scientists have developed a new diagnostic test that uses just a single drop of blood, costs a couple of dollars and delivers ...

Aarhus University researchers found that unusually strong synchronization between brain activity and the stomach’s slow ...

Researchers have developed a new engineered protein-based therapy, which acts like a sponge to soak up carbon monoxide from ...